Sign in
4

Changes in Ownership

PDS Biotechnology Corp Filed Acc 0001127602-17-023286

President and CEO sold 7,500 shares at an average $10.19 ($76,400)

From the SEC's structured data for this filing

Trades in this filing

Leuthner Brian A · President and CEO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2017-07-03 Sale : show line 1 in the form −2,500 $10.27 $25,675 132,736 D
2017-07-05 Sale : show line 2 in the form −2,500 $10.21 $25,525 130,236 D
2017-07-06 Sale : show line 3 in the form −2,500 $10.08 $25,200 127,736 D
Open-market sales · 7,500 sh · avg $10.19 · $76,400
Loading xslF345X03/form4.xml…